User:Paul Anders Fronth Nyhus

From OpenWetWare
Jump to navigationJump to search

I am a new member of OpenWetWare!

Contact Info

Paul Anders Fronth Nyhus (an artistic interpretation)

I work in the [Open LAB ] at XYZ University. I learned about OpenWetWare from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a coherent analytical framework for understanding the long term risks in relation to genetic engeneering and voluntary codes of conduct for dealing proactively with Biorisks , Biosafety , Biosecurity and Biodiversity Acces Benefit Sharing issues in Synthetic Biology Metabolic engennering Combinatorial Genomics and genome editing .Herein included Economic, Ethical, Legal and Social Issues as to maximize benefits ( for whom ? ) and minimize potential negative risks and unintended consequences if not sheer luddism and complete rejection from civil society.

Discussing the options by inclusion and involvement of stakeholders sui generis:Cui Bene

Education

  • Year, PhD, Institute
  • Year, MS, Institute
  • Year, BS, Institute

Research interests

  1. Comparative genomics of Aquaporins and gene regulation
  2. BioPatways2Bioprocess Green Chemistry Cell Free Systems and scaffolds
  3. MarineMicrobiomics Comparative genomics proteomics and metabolomics of Photosynthesis /E-Photosynthesis /Quantum Effects in Biology
  4. Comparative genomics of gene regulatory networks
  5. Evolution & Development & Ecology ( Evo Devo Evo Framework as applied to biology and to technology : Biomimetics &BioTriz)
  6. Converging technologies ( Bits Atoms Neurons & Genes )
  7. Neuromorphic computing deep learning /machinelearning and modelling as applied to life sciences /sequence structures functions and roles

Useful links

http://www.cdc.gov/OD/ohs/biosecurity_training/ http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm

One of the major challenges ahead is Antibiotics resistance How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/ Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ? http://www.gmo-compass.org http://www.who.int/drugresistance/whonetsoftware/en/ http://www.fda.gov/Fdac/features/795_antibio.html http://www.who.int/mediacentre/factsheets/fs194/en/